跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BISOLVON CHESTY (reformulation) bromhexine hydrochloride 0.8mg/mL oral liquid bottle - TGA Drug Approval Details
Approvals
/
TGA
/
BISOLVON CHESTY (reformulation) bromhexine hydrochloride 0.8mg/mL oral liquid bottle
Approved
STANDARD
BISOLVON CHESTY (reformulation) bromhexine hydrochloride 0.8mg/mL oral liquid bottle
Sanofi-Aventis Healthcare Pty Ltd T/A Sanofi Consumer Healthcare
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
5a01bdad7bf2ba0c
Company
Sanofi-Aventis Healthcare Pty Ltd T/A Sanofi Consumer Healthcare
Type
Standard
Approval Details
Approval Id
5a01bdad7bf2ba0c
Product Name
BISOLVON CHESTY (reformulation) bromhexine hydrochloride 0.8mg/mL oral liquid bottle
Artg Id
133244
Artg Name
BISOLVON CHESTY (reformulation) bromhexine hydrochloride 0.8mg/mL oral liquid bottle
Sponsor
Sanofi-Aventis Healthcare Pty Ltd T/A Sanofi Consumer Healthcare
Company Detail Path
/organization/sanofi-aventis-healthcare-pty-ltd
Artg Date
2006-11-27
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/7dc61a0fb284b85169b5fccc7fa62644.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/fd93104755901c04a56b5932cf4eaebb.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
5a01bdad7bf2ba0c
Type
Standard
Back to TGA Approvals
